Log inSign up

Palatin Technologies

0 followers

‌

Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system.

Industries

Biotechnology, Pharmaceutical

Headquarters

Cranbury, United States

Employees

51-200

Links

Org chart

CS
Carl Spana
CEO, President & Director

Carl Spana

Collapse
Stephen T. Wills
COO, CFO, Treasurer & Secretary
Stephen A. Slusher
Chief Legal Officer
Samrat Sisodia
VP, Regulatory Affairs & Quality Assurance
Michael B. Raizman
Chief Medical Officer
JD
John Dodd
SVP, Preclinical Development
Paul Kayne
VP, Biological Sciences
JW
J. Don Wang
VP, Product Development
Don Wang
Vice President, Prod Dev (CMC)
JL
Johna Lucas
Chief Medical Officer
John Prendergast
Co-Founder and Chairman of the Board

Teams

+8

Leadership Team

11 members

+3

Research and Development

6 members

+1

Clinical Operations and Regulatory Affairs

4 members

Similar companies

Kura Oncology

18 followers

Assembly Biosciences

9 followers

Adverum Biotech

8 followers

REVOLUTION Medicines

5 followers

Immunovant

5 followers

Summit Therapeutics

4 followers

Ocular Therapeutix

2 followers

Viridian Therapeutics

2 followers

AbbVie

178 followers

Hematogenix

1 follower

Fortis Life Sciences

1 follower

Explore companies